Hand Sanitizer Use for Herpes Simplex Virus-1

Description

The purpose of this pilot study is to determine if the use of Purell hand sanitizer alters the duration, level of pain and discomfort during treatment, and the size of the HSV-1 lesion. The duration of an HSV-1 (herpes) lesion is the primary endpoint for this study. Size, pain, and discomfort are the secondary endpoints.

Conditions

Virus, HSV-1, Herpes Simplex 1, Herpes Simplex Labialis

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this pilot study is to determine if the use of Purell hand sanitizer alters the duration, level of pain and discomfort during treatment, and the size of the HSV-1 lesion. The duration of an HSV-1 (herpes) lesion is the primary endpoint for this study. Size, pain, and discomfort are the secondary endpoints.

Herpes Simplex Virus-1: A Pilot Study Using Hand Sanitizer

Hand Sanitizer Use for Herpes Simplex Virus-1

Condition
Virus
Intervention / Treatment

-

Contacts and Locations

Pocatello

Idaho State University, Pocatello, Idaho, United States, 83209

Saint George

Cotton Creek Dental, Saint George, Utah, United States, 84780

Saint George

Utah Tech University, Saint George, Utah, United States, 84790

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * in the early prodromal stage of an HSV-1 outbreak (less than 24 hours from initial symptom)
  • * have a visible manifestation of a lesion
  • * be 18 years or older
  • * capable of following daily treatment instructions
  • * willing to complete a daily journal
  • * willing to come to the clinic twice for records and pictures during the14 days that the lesion is present or until participant is free of lesion.
  • * be immunocompromised
  • * be pregnant
  • * have taken any antiviral medication within the last two weeks
  • * have used any creams in the last ten days.

Ages Eligible for Study

18 Years to 99 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Leciel Bono,

Leciel Bono, MS, STUDY_CHAIR, Idaho State University

Study Record Dates

2023-11-30